Article
Implant shows success in treating posterior uveitis
Durham, NC-Results of a 9-month randomized, dose-masked, multicenter clinical trial of a fluocinolone acetonide sustained drug delivery system to treat posterior uveitis resulted in significant gains for the eyes that received implants when compared with fellow eyes that did not receive implants, said Glenn J. Jaffe, MD.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
